The view within: the emerging technology of thoracic electrical bioimpedance.
With the increasing incidence of catheter-related sepsis and recognition of increased mortality and cost of care with pulmonary artery catheters, the need for a safe, cost-effective, and clinically accurate means of obtaining hemodynamic data has become evident. Through the technology of thoracic electrical bioimpedance (TEB), non-invasive hemodynamic monitoring is now possible with the BioZ.com, manufactured by CardioDynamics International Corporation. The BioZ.com provides continuous hemodynamic readings safely, accurately, and inexpensively. TEB is proving to be a valuable adjunct to patient assessment and treatment across multiple health care settings.